Tobias Sjöblom – Finding and understanding cancer-causing molecular alterations
Our research focuses on molecular changes that are associated with cancer. The aim is to find and develop ways to use measurable molecular information for diagnosis and treatment for cancer.
We utilise molecular biology, databases and clinical data as well as patient material, cell lines and other tumour models to learn more about cancer development and how to detect and combat tumours effectively. Most of our work concerns colorectal cancer but in some projects we also study other types of cancer.
Our main areas of interest are:
- Identification of cancer-specific mutations and other aberrations in cancer cells.
- Investigation of how specific mutations contribute to tumour development or metastasis.
- Development of anti-cancer treatment that targets specific genetic properties of cancer cells.
- Identification of blood-borne biomolecules that are linked to occurrence of cancer.
- Development of methods to aid or improve diagnosis.
Ongoing research includes e.g. identification and functional studies of genetic aberrations in colorectal cancers, development of a novel cancer treatment and identification of biomarkers to enable blood-based cancer diagnostics tests.
Our strong interest in medical diagnostics has also led to several ongoing projects on development of automated image analysis software for use in clinical radiology.
Our research has previously resulted in spin-out companies to enable implementation of research results in health care. Oncodia AB develops CE/IVD approved software and reagent kits for application in clinical genomics that guides treatment selection.
Research infrastructure support
Translational cancer research is dependent on high quality patient materials and Tobias Sjöblom is Director of the U-CAN project, where clinical samples and information are collected from cancer patients for the purpose of supporting high quality research. He also heads the research infrastructure of Biobank Sweden.
Group members
Publications
Part of International Journal of Cancer, p. 488-503, 2024
Part of International Journal of Cancer, p. 40-53, 2024
- DOI for Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
- Download full text (pdf) of Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer
Part of Molecular Cancer, 2024
Part of Heliyon, 2024
Part of British Journal of Haematology, p. 1794-1803, 2024
- DOI for Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers
- Download full text (pdf) of Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers
Part of EBioMedicine, 2024
Prognostic genome and transcriptome signatures in colorectal cancers
Part of Nature, p. 137-146, 2024
Part of Cancers, 2024
Part of EBioMedicine, 2023
- DOI for An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
- Download full text (pdf) of An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
Part of Scientific Reports, 2023
Exact Probability Distribution for the ROC Area under Curve
Part of Cancers, 2023
Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
Part of Cell Death and Disease, 2023
Next generation pan-cancer blood proteome profiling using proximity extension assay
Part of Nature Communications, 2023
Part of Cell Communication and Signaling, 2023
Part of Cancers, 2023
Part of Biochemical Pharmacology, 2022
Part of Cancers, 2022
- DOI for Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions
- Download full text (pdf) of Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions
Part of Frontiers in Oncology, 2022
Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.
Part of Cancers, 2022
Profiling chromatin accessibility in formalin-fixed paraffin-embedded samples
Part of Genome Research, p. 150-161, 2022
Part of Cancers, 2021
- DOI for A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
- Download full text (pdf) of A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
Accurate population-based model for individual prediction of colon cancer recurrence
Part of Acta Oncologica, p. 1241-1249, 2021
Part of Journal of Experimental & Clinical Cancer Research, 2021
- DOI for Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis
- Download full text (pdf) of Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis
Part of Acta Oncologica, p. 842-849, 2021
Part of Nucleic Acids Research, 2021
Part of Radiotherapy and Oncology, p. 70-77, 2021
Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
Part of Pharmaceuticals, 2021
The Immune Landscape of Colorectal Cancer
Part of Cancers, 2021
Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort
Part of Annals of Surgical Oncology, p. 1036-1045, 2020
Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer
Part of Scientific Reports, 2020
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
Part of Nature Communications, 2020
Part of Acta Oncologica, p. 417-426, 2020
- DOI for Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis
- Download full text (pdf) of Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis
Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer
Part of Cancers, 2020
Recurrence Risk after Radical Colorectal Cancer Surgery: Less Than before, But How High Is It?
Part of Cancers, 2020
Part of Clinical Epigenetics, 2020
- DOI for Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression
- Download full text (pdf) of Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression
Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort
Part of Scientific Reports, 2020
Targeting tumor vulnerabilities associated with loss of heterozygosity
Part of Molecular & Cellular Oncology, 2020
Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N-Acetyltransferase NAT2
Part of Angewandte Chemie International Edition, p. 14342-14346, 2020
Part of Breast Cancer Research and Treatment, p. 459-467, 2019
- DOI for Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
- Download full text (pdf) of Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
Part of Scientific Reports, 2019
- DOI for Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
- Download full text (pdf) of Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
Part of Radiotherapy and Oncology, p. 106-112, 2019
Part of British Journal of Cancer, p. 303-311, 2019
Part of CANCER IMMUNOLOGY RESEARCH, 2018
Part of Genome Medicine, 2018
Part of Journal of Pathology, p. 421-431, 2018
Part of European Journal of Surgical Oncology, p. 1858-1864, 2018
Part of Acta Oncologica, p. 187-194, 2018
Part of Journal of Pathology, p. 311-322, 2018
- DOI for VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
- Download full text (pdf) of VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
A new distance measure for non-identical data with application to image classification
Part of Pattern Recognition, p. 384-396, 2017
A pathology atlas of the human cancer transcriptome
Part of Science, 2017
Part of BMC Cancer, 2017
Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity
Part of Oncotarget, p. 30217-30234, 2017
Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer
Part of Annals of Oncology, 2017
Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer
Part of Cancer Research, p. 1730-1740, 2017
Part of Oncotarget, p. 98646-98659, 2017
Targeted DNA sequencing and in situ mutation analysis using mobile phone microscopy
Part of Nature Communications, 2017
Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia
Part of Clinical Cancer Research, p. 6217-6227, 2016
Part of Blood, p. 1007-1016, 2016
Computational and molecular tools for scalable rAAV-mediated genome editing
Part of Nucleic Acids Research, 2015
Part of Haematologica, p. 10-11, 2015
Mutanome Engineered RNA Immunotherapy (MERIT)
Part of HUMAN GENE THERAPY CLINICAL DEVELOPMENT, p. 84-86, 2015
The Mutanome Engineered RNA Immuno-Therapy (MERIT) project
Part of Cancer Research, 2015
Transcriptional modulator ZBED6 affects cell cycle and growth of human colorectal cancer cells
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 7743-7748, 2015
Part of American Journal of Pathology, p. 1600-1609, 2015
Part of BMC Cancer, p. 872, 2014
Part of Molecular Cancer Therapeutics, p. 1964-1976, 2014
Part of Journal of Pathology, p. 253-261, 2014
Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15
Part of Cancer Research, p. 3408-3417, 2014
Automated serial extraction of DNA and RNA from biobanked tissue specimens
Part of BMC Biotechnology, p. 66, 2013
Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencing
Part of BMC Genomics, 2013
Part of Oncotarget, p. 2407-2418, 2013
STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer
Part of Cancer Research, p. 1287-1297, 2013
Validation of a yeast functional assay for p53 mutations using clonal sequencing
Part of Journal of Pathology, p. 441-448, 2013
Part of PLOS ONE, 2012
Part of European Journal of Cancer, 2012
Direct Detection of TMPRSS2-ERG Rearrangements in Prostate Cancer by Padlock Probes
Part of European Journal of Cancer, 2012
Part of PLOS ONE, 2012
Somatic mutations in the notch, NF-KB, PIK3CA, and hedgehog pathways in human breast cancers
Part of Genes, Chromosomes and Cancer, p. 480-489, 2012
Part of European Journal of Cancer, p. 396-406, 2012
Part of Genes, Chromosomes and Cancer, p. 82-94, 2011
Part of PLOS ONE, 2011
Targeted resequencing of candidate genes using Selector Probes
Part of Nucleic Acids Research, 2011
Efficient and scalable serial extraction of DNA and RNA from frozen tissue samples
Part of Chemical Communications, p. 547-549, 2010
Molecular pathways in tumor progression: from discovery to functional understanding
Part of Molecular bioSystems, p. 902-908, 2009
Part of American Journal of Pathology, p. 334-341, 2009
Part of Oncogene, p. 1218-1230, 2008
Part of Current Opinion in Oncology, p. 66-71, 2008
A multidimensional analysis of genes mutated in breast and colorectal cancers
Part of Genome Research, p. 1304-1318, 2007
Part of Molecular & Cellular Proteomics, p. 1500-1509, 2007
The genomic landscapes of human breast and colorectal cancers.
Part of Science, p. 1108-1113, 2007
An antibody-based method for monitoring in vivo oxidation of protein tyrosine phosphatases
Part of Methods, p. 37-43, 2005
Part of Cancer Research, p. 2725-2733, 2004
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 1886-1891, 2004
Smad2 suppresses the growth of Mv1Lu cells subcutaneously inoculated in mice
Part of European Journal of Cancer, p. 267-274, 2004
Part of American Journal of Pathology, p. 673-682, 2003
Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit
Part of Bioorganic & Medicinal Chemistry, p. 2007-2018, 2003